Boehringer Ingelheim Pharma GmbH & Co. KG

Interleukin 36 receptor-inducible matrix metalloproteinase 13 mediates intestinal fibrosis (2023) Koop K, Enderle K, Hillmann M, Ruspeckhofer L, Vieth M, Sturm G, Trajanoski Z, et al. Journal article N1-Methylnicotinamide as Biomarker for MATE-Mediated Renal Drug–Drug Interactions: Impact of Cimetidine, Rifampin, Verapamil, and Probenecid (2023) Müller F, Hohl K, Keller S, Schmidt-Gerets S, Deutsch B, Schuler-Metz A, Fromm M, et al. Journal article Decline in forced vital capacity in subjects with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial compared with healthy reference subjects (2022) Maher TM, Bourdin A, Volkmann ER, Vettori S, Distler J, Alves M, Stock C, Distler O Journal article Alveolar macrophages in early stage COPD show functional deviations with properties of impaired immune activation (2022) Bassler K, Fujii W, Kapellos TS, Dudkin E, Reusch N, Horne A, Reiz B, et al. Journal article "EFFECTIVE LUNG AGE" IN SUBJECTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE (SSC-ILD) IN THE SENSCIS TRIAL (2022) Maher T, Bourdin A, Volkmann E, Vettori S, Distler J, Alves M, Stock C, Distler O Conference contribution Multicomponent intervention to prevent mobility disability in frail older adults: randomised controlled trial (SPRINTT project) (2022) Bernabei R, Landi F, Calvani R, Cesari M, Del Signore S, Anker SD, Bejuit R, et al. Journal article Patient preferences for the treatment of systemic sclerosis-associated interstitial lung disease: a discrete choice experiment (2022) Bruni C, Heidenreich S, Duenas A, Hoffmann-Vold AM, Gabrielli A, Allanore Y, Chatelus E, et al. Journal article Nintedanib in Patients With Autoimmune Disease-Related Progressive Fibrosing Interstitial Lung Diseases: Subgroup Analysis of the INBUILD Trial (2022) Matteson EL, Kelly C, Distler J, Hoffmann-Vold AM, Seibold JR, Mittoo S, Dellaripa PF, et al. Journal article Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry. (2022) Lip GYH, Kotalczyk A, Teutsch C, Diener HC, Dubner SJ, Halperin JL, Ma CS, et al. Journal article Correction to: Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry. (2022) Lip GYH, Kotalczyk A, Teutsch C, Diener HC, Dubner SJ, Halperin JL, Ma CS, et al. Journal article, Erratum